...
首页> 外文期刊>Revista Argentina de Microbiologia >Fungemia following Saccharomyces cerevisiae var. boulardii probiotic treatment in an elderly patient
【24h】

Fungemia following Saccharomyces cerevisiae var. boulardii probiotic treatment in an elderly patient

机译:血液血症遵循酿酒酵母酿酒酵母 var。 boulardii 益生菌治疗在老年患者中

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The yeastSaccharomyces cerevisiaevar.boulardiiis a biotherapeutic agent used for the prevention and treatment of several gastrointestinal diseases. We report a case of fungemia in a patient suffering fromClostridiumdifficile-associated diarrhea and treated with metronidazole and a probiotic containingS. cerevisiaevar.boulardii.The yeasts isolated from the blood culture and capsules were identified by MALDI-TOF MS and API ID 32 C asS. cerevisiae,and showed the same appearance and color on CHROMAgar Candida. Treatment with fluconazole 400mg/day was initiated and the probiotic was stopped. The patient was discharged from hospital in good condition and was referred to a rehabilitation center. We suggest that the potential benefit ofS. cerevisiaevar.boulardiishould be accurately evaluated, especially in elderly patients. Moreover, all physicians should be trained in the use of probiotic agents and enquire whether the use probiotics was included in the patients’medical histories.
机译:酵母酵母菌酿酒酵母遗传赛赛赛赛赛虫草。生物治疗剂用于预防和治疗几种胃肠疾病。我们举报了患有患有Clostridifificile相关的腹泻的患者的功能性,并用甲硝唑和益生菌容纳治疗。 Cerevisiaevar.boulardii。由MALDI-TOF MS和API ID 32 C ASS鉴定出从血液培养和胶囊中分离的酵母。 Cerevisiae,并在Chromagar Candida上表现出相同的外观和颜色。引发氟康唑400mg /天的处理,并停止益生菌。患者以良好的状态从医院排放,并提到了康复中心。我们建议潜在的利益。 Cerevisiaevar.boulardihishould被准确评估,特别是在老年患者中。此外,所有的医生都应该接受培训益生菌药物并询问患者的医疗历史是否包含使用益生菌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号